LACTOSE, UNSPECIFIED FORM

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
342.0 -5.4 8 11 190.0 4 1.0
UNII
J2B2A4N98G
SYNONYMS
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Oral Powder, For Solution
Buccal Tablet 183.3MG
Buccal/sublingual Tablet 296.7MG
Im - Iv Injection 20.35%
Im - Iv Powder, For Injection Solution
Im - Iv - Sc Injection
Im - Iv - Sc Powder, For Injection Solution 13.3%
Inhalation Capsule 20MG
Inhalation Capsule, Hard Gelatin 25MG
Inhalation Powder 9%
Intracavitary Powder, For Injection Solution, Lyophilized 19.38%
Intramuscular Injection
Intramuscular Powder, For Injection Solution 2%
Intramuscular Powder, For Injection Solution, Lyophilized 1%
Intravenous Injection 50%
Intravenous Powder, For Injection Solution 5%
Intravenous Powder, For Injection Solution, Lyophilized 1%
Iv(infusion) Injection
Iv(infusion) Powder, For Injection Solution
Iv(infusion) Solution, Injection 0.45%
Oral Capsule 530MG
Oral Capsule, Coated Pellets 102.44MG
Oral Capsule, Delayed Action, Enteric Coated
Oral Capsule, Enteric Coated Pellets 135.2MG
Oral Capsule, Hard Gelatin 100MG
Oral Capsule, Soft Gelatin 115.75MG
Oral Capsule, Sustained Action 120MG
Oral Concentrate
Oral Granule, For Suspension
Oral Solution 11.21%
Oral Tablet 2217MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 117.7MG
Oral Tablet, Coated 332.05MG
Oral Tablet, Controlled Release 0.02MG
Oral Tablet, Delayed Action 92.02MG
Oral Tablet, Delayed Action, Enteric Coated 209MG
Oral Tablet, Delayed Release
Oral Tablet, Extended Release 122.99MG
Oral Tablet, Film Coated 590MG
Oral Tablet, Multilayer, Extended Release 122MG
Oral Tablet, Repeat Action 153.2MG
Oral Tablet, Sustained Action 400MG
Oral Tablet, Sustained Action, Film Coated 51.1MG
Oral Tablet, Sustained Release, Film Coated 38.75MG
Oral-20 Tablet 70.7MG
Oral-21 Tablet 89.28MG
Oral-28 Tablet 179.2MG
Rectal Solution 8%
Rectal Tablet 20MG
Subcutaneous Powder, For Injection Solution 2%
Subcutaneous Powder, For Injection Solution, Lyophilized 0.5%
Sublingual Tablet 175.92MG
Topical Emulsion, Cream
Transdermal Film, Controlled Release 675MG
Transdermal Ointment 18.9%
Vaginal Emulsion, Cream 3%
Vaginal Suppository
Vaginal Tablet 1013MG

More Information

Usage Over Time

Comments